Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Oncogene.
2019,
38(40),
6711-6722,
ISSN: 0950-9232,
PMID: 31391554,